NGEN NERVGEN PHARMA CORP.
Price Chart
Executive Summary
The SEC declared effective NERVGEN PHARMA CORP.'s registration statement (File No. 333-296217) on May 26, 2026, under the Securities Act of 1933. This allows the company to offer and sell securities, likely common shares, from time to time, creating potential dilution overhang for existing shareholders.
Actionable Insight
Monitor the company for any takedown announcements from the shelf, as share issuances could pressure the stock. The shelf provides flexibility for capital raises, which may be used for pipeline funding or general corporate purposes.
Key Facts
- Effectiveness date: May 26, 2026
- SEC File No. 333-296217
- The registration statement covers an unspecified amount of securities to be offered periodically
Financial Impact
Potential dilution from future offerings; no specific amount set
Risk Factors
- Dilution overhang from potential future offerings
- Uncertainty about timing and size of any offering
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001763 |
| Document: 9999999995-26-001763-index.html | 9999999995-26-001763 |
| Document: 9999999995-26-001763.txt | 9999999995-26-001763 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
11d ago
|
6-K
| $2.00 $1.91 | ▲ +4.50% | ▲ +3.78% | $1.92 (+4.00%) |
|
May 27, 2026
17d ago
|
EFFECT
| $2.07 $2.08 | ▲ +0.48% | ▼ −0.07% | $1.92 (−7.25%) |
|
May 26, 2026
17d ago
|
6-K
| $2.07 $2.08 | ▲ +0.48% | ▼ −0.06% | $1.92 (−7.25%) |
|
May 22, 2026
21d ago
|
6-K
| $2.13 $2.07 | ▲ +2.82% | ▲ +2.83% | $1.92 (+9.86%) |
|
May 22, 2026
22d ago
|
Press Release
| $2.08 $2.13 | ▼ −2.40% | ▼ −1.82% | $1.92 (+7.69%) |
|
May 21, 2026
22d ago
|
Press Release
| $2.08 $2.13 | ▼ −2.40% | ▼ −1.82% | $1.92 (+7.69%) |
|
May 18, 2026
25d ago
|
6-K
| $3.56 $3.74 | ▲ +5.06% | ▲ +4.02% | $1.92 (−46.07%) |
|
May 18, 2026
26d ago
|
Press Release
| $3.64 $3.56 | ▲ +2.20% | ▲ +1.55% | $1.92 (+47.25%) |
|
Apr 27, 2026
6w ago
|
6-K
| $3.88 $3.75 | ▼ −3.41% | ▼ −3.40% | $1.92 (−50.52%) |
|
Mar 31, 2026
10w ago
|
Press Release
| $3.77 $4.36 | ▲ +15.65% | ▲ +14.90% | $1.92 (−49.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access